miR199a represses the proliferation of hepatocellular carcinoma cells by targeting SGK3 through Akt/mTOR pathway

Author:

Wu Ting1,Qi Guilin1,Liu Pan1,Li Jing1,Guo Min1,Yu Hui1,Yang Huidongfang1,Jin Yuyin1,Zhou Wen1,Hu Wangheng1,Yu Han1,Duan Peng1

Affiliation:

1. Hubei University of Medicine

Abstract

Abstract Purpose Previous studies have suggested that some microRNAs (miRNAs) play a vital role in carcinogenesis and progression of hepatocellular carcinoma (HCC). As one of these newly found miRNAs, miR-199a-3p (miR199a), has been shown to be highly involved in the regulation of HCC growth. However, the mechanism underlying miR199a regulation in HCC remains unclear. Methods In this study, the evaluation of miR199a expression in HCC cells (HCCs) and tissues was evaluated by RT-qPCR. Bioinformatics analysis and luciferase reporter assay were performed to prove the regulation effect of miR199a on SGK3. CCK-8 assay was performed to assess the proliferation of HCCs (HepG2 and HuH7) after transfection. Subsequently, the biological function of miR199a/SGK3 axis in HCCs was investigated. Results Herein, we found that miR199a is usually underexpressed in the HCC tissue and cell lines (HepG2 and HuH7) compared with their corresponding control. The expression pattern of SGK3, as a direct target of miR199a, was opposite that of miR199a. shRNA-mediated silencing of SGK3 decreased the proliferation of HCC cells (HCCs) in vitro; however, these phenotypes were promoted by miR199a mimics. Mechanistically, miR199a inhibited the proliferation of HCCs through the downregulation Akt/mTOR signalling by targeting SGK3. Conclusion our findings demonstrated an important role for SGK3 as a miR199a target and a mediator of the Akt/mTOR signaling pathway. These findings highlight the miR199a/SGK3 axis as a potential therapeutic target for managing HCC.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3